HCA
HCA Healthcare, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 11 ▼ 2 insiders sell $6.1M at $511.39
- Apr 27 Tyler Fallon v. Wilson Medical Center; HCA Florida Kendall…
- May 15 ▼ Ro Khanna sold $1,001 - $15,000, last disclosed Jun 11
- Jun 4 Dawne G. McCammon v. Bankers Healthcare Group, LLC
- Jun 17 to Jun 30 ▲ 2 buys: Jared Moskowitz, William Keating bought, last disclosed Aug 14
- Jul 8 ▼ Barclays downgrades
- Jul 14 ▼ HCA Healthcare issued preliminary Q2 2026 results and revised 2026 g…
- Jul 20 ▲ Ro Khanna bought $1,001 - $15,000, last disclosed Aug 12
- Sep 4 ▲ Ro Khanna bought $1,001 - $15,000, last disclosed Oct 9
- Sep 23 BMO Capital initiates
- Oct 27 ▲ Earnings: HCA Q3 2026 Earnings: EPS $7.22 (+7.3% vs est)
- Nov 4 to Nov 10 ▼ 3 days of insider sells: $18.3M by 3 insiders, avg $501.23
Signal stack
Where each data set points today.
- InsidersBEARISH
5 insiders sold $24.4M.
- InstitutionsMIXED
Q3 2026: 36 added (1 new), 49 trimmed or exited. Largest new: Quadrature Capital $20.3M.
- AnalystsBULLISH
18 of 31 rate it Buy or better. Median target $488.00 (−5%).
- Short sellersSTEADY
Short interest −2.1% to 4.80M shares. 3.3 days to cover, ≈2.3% of shares.
- TrendUPTREND
13% above its 50-day average.
- SocialQUIET
Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup is alerting.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| Capital World Investors | ADD | $1.1B |
| Amundi | ADD | $246.1M |
| Quantinno Capital Management LP | ADD | $125.8M |
| BNP PARIBAS FINANCIAL MARKETS | ADD | $123.2M |
| HRT FINANCIAL LP | DOUBLED | $118.9M |
| JANE STREET GROUP, LLC | DOUBLED | $109.0M |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | ADD | $96.5M |
| Ensign Peak Advisors, Inc | ADD | $90.0M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
31 analystsPrice is inside the target range. Median implies −5%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 3, 2026 | Truist Securities REITERATE | Buy |
| Nov 2, 2026 | Wells Fargo MAINTAIN | Equal-Weight |
| Oct 30, 2026 | RBC Capital MAINTAIN | Outperform |
| Oct 29, 2026 | Barclays MAINTAIN | Equal-Weight |
| Oct 28, 2026 | TD Cowen MAINTAIN | Buy |
| Oct 28, 2026 | Keybanc MAINTAIN | Overweight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Rossitto Erica SVP & Chief Nurse Executive Nov 10, 2026 | SELL | $1.8M |
Foster Jon M EVP and COO Nov 6, 2026 | SELL | $1.3M |
Foster Jon M EVP and COO Nov 6, 2026 | SELL | $730.1K |
Foster Jon M EVP and COO Nov 6, 2026 | SELL | $3.8M |
Foster Jon M EVP and COO Nov 6, 2026 | SELL | $529.7K |
Foster Jon M EVP and COO Nov 6, 2026 | SELL | $444.1K |
Foster Jon M EVP and COO Nov 6, 2026 | SELL | $3.1M |
Foster Jon M EVP and COO Nov 6, 2026 | SELL | $838.6K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026Washington
SecBot reports
19 filings · 0 bullish · 1 bearish · 1 mixed · 17 neutral- NEUTRAL 144Nov 10, 2026
Erica Rossitto, an officer of HCA Healthcare, filed a Form 144 notice of intent to sell 3,500…
This is a routine insider sale for tax withholding purposes related to a stock award vesting. The small size relative to market cap and the compensatory nature suggest no material signal about the…
- NEUTRAL SC 13D/ANov 6, 2026
The Frist family group filed an amended Schedule 13D for HCA Healthcare, reporting updated…
This filing is purely administrative with no change in the Frist group's economic exposure or activist posture. Monitor future filings for any actual stake changes or new demands.
- NEUTRAL CLUSTERNov 6, 2026
Two HCA executives (EVP/COO Foster and EVP/Chief Clinical Officer Schlosser) conducted open-market…
The dollar amount of insider sales is negligible for a company of HCA's size. Monitor next quarter's payer mix trends and leverage metrics given the recent debt issuance, but this cluster alone does…
- NEUTRAL CLUSTERNov 6, 2026
Two HCA executives (EVP/COO Foster and EVP/Chief Clinical Officer Schlosser) sold a combined…
The insider sales are small and routine relative to HCA's size. Monitor next 10-Q for any change in operating trends, particularly the $400M unfavorable payer mix shift noted in Q3 earnings.
All HCA filing & press-release reports (19)
- 144 reportNov 10, 2026
- SC 13D/A reportNov 6, 2026
- CLUSTER reportNov 6, 2026
- CLUSTER reportNov 6, 2026
- 8-K reportNov 5, 2026
- 144 reportNov 4, 2026
- 144 reportNov 4, 2026
- 8-K reportNov 2, 2026
- 144 reportOct 29, 2026
- INST-CLUSTER reportOct 28, 2026
- 8-K reportOct 27, 2026
- 8-K reportJul 24, 2026
- 8-K reportJul 14, 2026
- 8-K reportJun 18, 2026
- COURT-RULING reportApr 27, 2026
- 8-K reportApr 27, 2026
- 8-K reportApr 24, 2026
- DEFA14A reportMar 13, 2026
- 8-K reportFeb 25, 2026